Participants Required For Men’s Testosterone Study

Categories: ,

Group of men.

Professor David J Handelsman (Andrology Dept, Concord Hospital, ANZAC Research Institute, Sydney) is looking to recruit 15 healthy male volunteers to participate in a new testosterone study titled ‘Pharmacokinetics of Testosterone Cream Applied to Scrotal Skin’

The conventional use of testosterone cream, gel and solutions has been to the upper body in testosterone deficient men. Due to low absorption rates residual testosterone can be transferred to partners and children via contact with the skin to which the testosterone has been applied. This study will examine the absorption of testosterone cream when applied to scrotal skin which opens the potential to avoid passive transfer problems.

The study is seeking 15 men that meet the following criteria;

  • healthy and aged between 18 and 50
  • able to make 5 visits within a 12 day period, including 3 x 16 hour visits to the clinic
  • have normal reproductive endocrine function.

If you are interested in participating please complete this screening questionnaire link www.lawleypharm.com.au/tstudy.php.

Participants will be compensated for their time and travel expenses at the end of participating in the study.

Latest News


AndroFeme 1 included on ARTG for hypoactive sexual desire dysfunction in postmenopausal women AndroFeme 1 included on ARTG for hypoactive sexual desire dysfunction in postmenopausal women

Lawley Pharmaceuticals’ female-specific hormone cream, AndroFeme® 1, has been registered on the Australian Register of Therapeutic Goods (ARTG) for the treatment of postmenopausal women… Continue Reading →

The Menopause Charity launches in the UK The Menopause Charity launches in the UK

Menopause specialist Dr Louise Newson has launched a new Crowdfunding campaign for The Menopause Charity, which she hopes will change millions of women’s lives… Continue Reading →

Tanner Pharma Group and Lawley Pharmaceuticals Initiate Global Named Patient Program for AndroFeme® 1 Tanner Pharma Group and Lawley Pharmaceuticals Initiate Global Named Patient Program for AndroFeme® 1

Friday 12th June 2020 Perth, Australia and Charlotte, USA – Lawley Pharmaceuticals and Tanner Pharma Group announced today that they have initiated a global… Continue Reading →